Fulvestrant 25021-0471-66

Package NDC

25021-0471-66

Manufacturer: Sagent Pharmaceuticals
Dosage Form: Injection, Solution
Route: Intramuscular
Product Type: Human Prescription Drug
Marketing Start: April 15, 2026
Listing Expires: December 31, 2027
Application: ANDA211422

Need to source Fulvestrant? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Fulvestrant	50 mg/mL

Drug Class

Estrogen Receptor Antagonist [EPC]Estrogen Receptor Antagonist [EPC]Estrogen Receptor Antagonists [MoA]

Selected Package

25021-0471-66Selected

2 SYRINGE in 1 CARTON (25021-471-66) / 5 mL in 1 SYRINGE